Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational Cohort Study to Evaluate the Clinical Impact of Novel Monoclonal Antibodies (MAB) in B-cell Non-Hodgkin Lymphoma (NHL) in Italian Clinical Practice

NCT06008691 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.

NCT NCT06008691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06008691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational Cohort Study to Evaluate the Clinical Impact of Novel Monoclonal Antibodies (MAB) in B-cell Non-Hodgkin Lymphoma (NHL) in Italian Clinical Practice
Lead sponsor
Fondazione Italiana Linfomi - ETS
Phase
Observational
Overall status
Recruiting
Start date
December 27, 2023
Completion date
October 31, 2038
Enrollment
1,500 (estimated)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkin lymphoma, b-cell